Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

February 5, 2021 10:40 PM UTC
Updated on Feb 6, 2021 at 1:48 AM UTC

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) promoted Osamu Okuda to CEO from president and COO, succeeding Tatsuro Kosaka who will remain chairman. Okuda, who joined Chugai in 1987, has served as president of Roche Products (Ireland) Ltd., head of oncology marketing and sales, GM of corporate planning and co-head of life-cycle management. The move is effective March 23; Chugai is majority owned by Roche (SIX:ROG; OTCQX:RHHBY).

Astellas Pharma Inc. (Tokyo:4503) promoted Percival Barretto-Ko from U.S. president to chief business officer. The company also promoted Astellas Institute for Regenerative Medicine President Yoshitsugu Shitaka to CSO. Mark Reisenauer, former SVP of the oncology business unit, will succeed Barretto-Ko as U.S. president, and Masahide Goto will succeed Shitaka as AIRM president...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article